| Dr Mary Melissa Morgan, MD | |
|
1621 S Eucalyptus Ave, Suite 202, Broken Arrow, OK 74012-5940 | |
| (918) 459-7546 | |
| (918) 459-7575 |
| Full Name | Dr Mary Melissa Morgan |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 34 Years |
| Location | 1621 S Eucalyptus Ave, Broken Arrow, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487621413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | 20128 (Oklahoma) | Primary |
| Entity Name | Melissa Morgan Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518232230 PECOS PAC ID: 8729240700 Enrollment ID: O20120509000261 |
News Archive
African-American men face a higher risk of developing prostate cancer in their lifetime, but researchers do not fully understand why.
Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia.
The American Society of Pediatric Otolaryngology will recognize the outstanding achievements of researchers in the field of pediatric otolaryngology during their annual meeting, April 29 - May 1, 2011, in Chicago, IL.
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary Melissa Morgan, MD 1621 S Eucalyptus Ave, Sutie 202, Broken Arrow, OK 74012-5940 Ph: (918) 459-7546 | Dr Mary Melissa Morgan, MD 1621 S Eucalyptus Ave, Suite 202, Broken Arrow, OK 74012-5940 Ph: (918) 459-7546 |
News Archive
African-American men face a higher risk of developing prostate cancer in their lifetime, but researchers do not fully understand why.
Dementia patients may benefit from a promising new treatment called Cerebrolysin, according to the results of a systematic review published in The Cochrane Library. The authors brought together the most up-to-date evidence on Cerebrolysin as a treatment for vascular dementia.
The American Society of Pediatric Otolaryngology will recognize the outstanding achievements of researchers in the field of pediatric otolaryngology during their annual meeting, April 29 - May 1, 2011, in Chicago, IL.
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication in the journal PLoS Medicine of groundbreaking clinical research indicating the broad immunological and commercial potential of Vaxxas' novel high-density microarray patch.
› Verified 8 days ago
Dr. Carlos Gomez-meade, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 W. Boise Circle, Suite 400, Broken Arrow, OK 74012 Phone: 918-307-0215 Fax: 918-250-7669 | |
Dr. Lise D Brown, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 W Boise Cir Ste 400, Broken Arrow, OK 74012 Phone: 918-307-0215 Fax: 918-250-7669 | |
Dr. Janelle Marshall Pavlis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 W Boise Cir Ste 400, Broken Arrow, OK 74012 Phone: 918-307-0215 Fax: 918-250-7669 |